|
|
|
|
| TRADING CENTER |
47.01+0.62 / +1.34%
Gilead Sciences Inc (NASDAQ GS:GILD)
47.00-0.01 / -0.02
After hours quote
Prev. Close:
46.39
Open:
46.93
High:
47.13
Low:
46.54
Volume:
4,848,149
Volume Avg.:
7,772,300
52wk Range:
39.37 - 53.28
Market Cap (mil):
42,305.47
P/E Ratio:
18.15
Dividend Yield:
N/A
| The Highest Possible Returns. Period. - MotleyFool.com | |
| J&J stays true to its diversified model - FT.com | |
| Now's a Great Time to Invest -- So Don't Blow It Like This - MotleyFool.com | |
| 5 Stocks Geared for Growth - MotleyFool.com | |
| 5 Stocks Making Cash - MotleyFool.com | |
| A Big Upgrade for Sanofi-Aventis - MotleyFool.com | |
| The Worst Stocks to Buy Today - MotleyFool.com | |
| The Hottest Sector for 2010 - MotleyFool.com | |
| 5-Star Stocks Poised to Pop: American Oriental Bioengineering - MotleyFool.com | |
| Gilead Awaits Committee Outcome - Analyst Blog - Zacks.com | |
| Gilead Sciences to Present at the Lazard Capital Markets 6TH Annual Healthcare Confer... - Business Wire | |
| 5-Star Stocks Worth a Look - MotleyFool.com | |
| Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and ... - Zacks.com | |
| A Big Upgrade for Gilead Sciences - MotleyFool.com | |
| Cramer on BloggingStocks: Pelosi can't kill the health care sector - Bloggingstocks.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 56.25 | 0.87 / 1.57% | 10.76 |
| CELG | Celgene Corporation | 55.65 | 0.74 / 1.35% | 67.05 |
| BIIB | Biogen Idec Inc | 46.79 | 0.41 / 0.88% | 15.70 |
Short Interest Date:
Oct 30 2009
Short Interest Shares:
16,198,837
Short Interest Ratio:
1.9
Float:
898,959,831
Short Interest as a % of Float:
1.8%
Average Daily Volume:
8,186,900
Outstanding Shares:
899,925,051
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company develops and markets therapies to treat life-threatening infectious diseases, and acquisitions are broadening this focus to include ... (more)
| 2008 Revenue: | $5.3 B | Headquarters: Foster City, CA |
| Employees: | 3,441 | CEO: Dr. John C. Martin, M.D., Ph.D. |
| Net Income: | $2.0 B | Industry: Biotechnology |
| Market Cap: | $41.7 B | Website: www.gilead.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| GILD | 47.01 | +0.62 / +1.34% | 46.39 | 47.13 | 46.54 | Profile Chart News |
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
